Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Avid Transitions Into CDMO By Offloading Cancer Program To Oncologie

Feb 12 2018

• By Joseph Haas and Ying Huang

DealWatch_1200x675

Related Content

Puma's Nerlynx Scores Broad Label Across Adjuvant Breast Cancer Subgroups

Jul 18 2017

The Next Roivant Or Fortress? BridgeBio Raises $135m To Spin Out New Companies

Sep 18 2017

Pieris And Seattle Strike IO Deal

Feb 12 2018

Poxel's Phase III Oral Diabetes Therapy Taken Up By Roivant

Feb 12 2018

Deal Watch: Sanofi Finds Ideal 'Partner' For Leukine

Feb 01 2018

AstraZeneca Links With Alibaba And Tencent In China 'Digital Health' Push

Feb 04 2018

Theravance Banks $100m As J&J Bets Big On IBD Drug

Feb 07 2018

Related Companies

Avid Bioservices, Inc.

BridgeBio Pharma, Inc.

Novartis AG

Navire Pharma, Inc.

PellePharm, Inc.

Lonza Group AG

Denali Therapeutics Inc.

Daré Bioscience, Inc.

Cerulean Pharma Inc.

ProBioGen AG

Teva Pharmaceutical Industries Ltd.

Pfizer Inc.

Puma Biotechnology, Inc.

CANbridge Pharmaceuticals Inc.

Apogenix AG

AVEO Pharmaceuticals, Inc.

Medison Pharma Ltd.

Poxel SA

Roivant Sciences Ltd.

Pieris Pharmaceuticals, Inc.

Seagen Inc.

Johnson & Johnson

Theravance Biopharma Inc.

AstraZeneca PLC

Additional Topics

Deals Business Strategies Commercial M & A BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window